Testimony
Nancy J. Norton, President and Founder of IFFGD presented the following testimony regarding Fiscal Year 2006 Funding for Functional Gastrointestinal and Motility Disorders Research before the House Appropriations Subcommittee on Labor, Health & Human Services, Education and Related Agencies in 2005: Chairman Regula and members of the Subcommittee, thank you for the opportunity to present […]
Testimony
Nancy J. Norton, President and Co-Founder of IFFGD submitted the following written statement regarding Fiscal Year 2009 appropriations for the National Institutes of Health to the Senate Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies on April 28, 2008: Thank you for the opportunity to present this written statement […]
Testimony
IFFGD Founder and President, Nancy Norton, submitted the following written statement to the House Committee on Appropriations; Subcommittee on Labor, Health and Human Services, Education and Related Agencies regarding Fiscal Year 2010 appropriations for the National Institutes of Health on May 1, 2009: Thank you for the opportunity to present this written statement regarding the […]
News Article
IFFGD Presents 2018 Research Recognition Awards at DDW Four young investigators honored for contributions to the field of digestive health For Immediate Release Media Contact Form IFFGD 414-964-1799 MILWAUKEE, WI (May 29, 2018) — In recognition of the importance of research in shaping the future of the treatment and care of chronic digestive disorders, the […]
Award for Clinical Science Investigator Dr. Christopher Almario’s research is focused on developing and validating innovative, scalable, evidence-based technologies that support patients and clinicians in making shared decisions that improve health and reduce costs. He has also conducted a number of studies that deepen our understanding of the epidemiology and impact of functional gastrointestinal disorders […]
View the Education Program For the millions of Americans living with the debilitating and sometimes life-threatening symptoms of a chronic gastrointestinal (GI) or motility disorder, the fight for awareness, research into safe and effective treatments, and cures are ongoing. But Members of Congress can help. IFFGD’s Virtual Advocacy Event will be a week long event educating […]
On June 23rd, 2016 patients, family members and friends, health care providers, researchers, and members of the public across the US reached out to their House Members of Congress through email, phone, and social media on behalf of The Functional Gastrointestinal and Motility Disorders Research Enhancement Act (HR 2311). You shared your unique personal story […]
Disorder
In chronic pain, we have strong evidence that our pain modulation system is not working well. Instead ofsuppression, the system may be over-sensitized so that even normal sensations trigger pain transmission and suffering. As a result of the pain, patients may also have increased levels of anxiety and depression, decreased quality of life, fear of […]
Virtual Advocacy Day: July 21st, 2015 On July 21st, 2015 the Digestive Health Community stood up for the needs of all those affected by functional GI or motility disorders On Tuesday, July 21st, 2015 people came together from across the United States to take part in IFFGD’s 2015 Virtual Advocacy Day. On this day patients […]
In recognition of the importance of research in shaping the future of the treatment and care of chronic digestive disorders, IFFGD was pleased to honor four young investigators as recipients of the 2018 IFFGD Research Recognition Awards. The awards support and encourage the participation of clinicians and scientists in multidisciplinary efforts aimed at providing a better […]
Disorder
“Motility” is a term used to describe the contraction of the muscles that mix and propel contents in the gastrointestinal (GI) tract. The gastrointestinal tract is divided into four distinct parts that are separated by sphincter muscles; these four regions have distinctly different functions to perform and different patterns of motility (contractions). They are the […]
Testimony
The following written comments were submitted by IFFGD president, Ceciel T. Rooker, to the US Food and Drug Administration (FDA) in connection with a October 18, 2018 joint meeting of the FDA Gastrointestinal Drugs Advisory Committee and Risk Management Advisory Committee to discuss the reintroduction of Zelnorm: The International Foundation for Gastrointestinal Disorders (IFFGD) […]
This information is in no way intended to replace the guidance of your doctor.
We advise seeing a physician whenever a health problem arises requiring an expert’s care.
© Copyright 2025 International Foundation for Gastrointestinal Disorders, Inc. (IFFGD).
All Rights Reserved.
Keep up-to-date on the latest news, stories, tips, research highlights, and more!
